Made for Pharmacists

As a company, we value the lives of pharmacists. That’s why we are dedicated to providing the best possible medical solutions to ensure the safety of pharmacists.
Guidelines

Safety for Pharmacists with the Tevadaptor® Closed System Transfer Device (CSTD)

Numerous studies show that classic syringe and needle techniques almost universally result in contamination, including droplets, leakage from vial stoppers and aerosol generation 1. For pharmacists working with hazardous drugs, this contamination can be a significant health risk.

Exposure to antineoplastic drug contamination can occur at all stages from compounding to reconstitution through inhalation, skin contact, unintentional hand-to-mouth ingestion, or needle stick and sharps injury. Routine handling of hazardous drugs in pharmacy has been shown to lead to higher risks of chromosomal aberrations 2. The acute effects of exposure to hazardous drugs can include skin rashes and nausea, while chronic effects extend to infertility, miscarriages, birth defects, leukemia and other cancers 3.

There are also other hazards in pharmacy. The use of higher doses and more combinations in modern therapy, and the increasing use of new therapies such as anti-virals and monoclonal antibodies may also increase health risks for pharmacists 4.

    The Evolution of Safe Handling Guidelines

    Starting in the 1970s, studies demonstrated the risks associated with exposure to hazardous drugs. Beginning in 1990, guidelines from the American Society of Health-System Pharmacists (ASHP) listed recommendations for healthcare professionals who work with hazardous drugs.

    In 2004, NIOSH published guidelines for safe handling of hazardous drugs by pharmacists. Further guidelines from the International Society of Oncology Pharmacy Practitioners (ISOPP) followed in 2007. Additional organizations, including OSHA, ONS, HOPA and others have issued their own recommendations for pharmacist safety 5.

      Safe Handling Made Simple

      In combination with using personal protective equipment (PPE), best practices and other controls, Tevadaptor® provides safety by minimizing exposure to hazardous substances, including fluids, aerosols and vapors, while maintaining drug sterility.

        Focusing on Your Safety so You Can Focus on What Really Matters

        The Tevadaptor® system is a premium closed system transfer device (CSTD) with patented double membrane air-cleaning technology that enables safe handling, compounding, preparation and administration of antineoplastic and other hazardous drugs. 

        Cleared by the FDA under the ONB product code and CE approved, Tevadaptor® has additional worldwide health ministry approvals, including in Japan, Canada and Israel
        .

          Patented Double Membrane Air-cleaning Technology

          Meeting the NIOSH definitions for CSTDs, Tevadaptor®’s patented double membrane air-cleaning technology, known as Toxi-Guard®, provides pharmacists with safety at the highest standards when handling dangerous drugs. Toxi-Guard® prevents the escape of toxic drug vapors, aerosols and drops while preserving the sterility of the drug or fluid path. Toxi-Guard® also enables automatic pressure equalization.

            Simply Click for Safety

            It’s safe. Tevadaptor® has a proven record of excellent performance. The system is scientifically validated to prevent hazardous drug leakage 6. Surface contamination is also dramatically reduced with the use of the Tevadaptor® CSTD 7, 8.

            It’s simple. Tevadaptor® is designed to be intuitive. Because Tevadaptor® is so easy to use, pharmacists can expect to experience fewer errors, spills, accidental exposures and fatigue and repetitive stress injury.

            Complies with European Sharps Directive. By containing the needle entirely in the septum, Tevadaptor® eliminates exposure to needles.

            Just click. The audible “click” of Tevadaptor®’s elastomer-to-elastomer connection confirms that a safe, closed connection has been established.

            Cost efficient. Tevadaptor® has been shown to maintain drug sterility and stability for up to 28 days 9, enabling both cost savings and drug savings 10. It also means lifesaving treatment can be provided to more patients.

              Tevadaptor®. Leading Solutions for Pharmacist Safety

              At Tevadaptor®, we are dedicated to providing the best possible medical solutions to ensure safety in the healthcare workplace.

              1. JOPP, 2007; 13 (Supplement): 1-81pp
              2. Mutat Res. 1994 Sep 1;309(2):193-9
              3. NIOSH Publication Number 2004-165
              4. JOPP, 2010, 17 (1):68-80
              5. AM J Health-Syst Pharm. 2006 63(12) 1172-1191
              6. ASHP 2016 mid-year MPM 4?173
              7. ASHP 2016 mid-year MPM 4-115
              8.
              Eur J Hosp Pharm 2018, 25: A241
              9. ECOP Conference 2014 Poster
              10. Drugs Ther Perspect 2016 32:170-176